Media Center

2/09/11 - Matan Development Delivers National Cancer Institute's World-Class Research & Development Facility Ahead of Schedule

Matan Companies, developer of National Cancer Institute’s 332,000-SF Advanced Technology Research Facility at Riverside Research Park in Frederick, Maryland, delivered the shell building 29 days ahead of schedule to SAIC-Frederick, to begin the tenant fit-out construction. “This project was anything but your typical office building construction. The facility was largely designed from the inside out to accommodate the unique specifications required to become a truly state-of-to-art research and development laboratory and manufacturing facility,” said Karl Morris, Director of Development for Matan Companies.

Morgan-Keller constructed the core and shell of the National Cancer Institute building, and site work and construction of the core and shell took approximately 15 months to complete. The project is comprised of four individual tilt-up concrete structures, connected via a three-story atrium. The Whiting-Turner Contracting Company was awarded general contractor for the $113M interior tenant improvements, which commenced on December 14, 2010 and are anticipated to be complete by Summer 2012.*

This state-of-the-art facility is a government-owned, contractor-operated National Laboratory, with SAIC-Frederick, Inc. as its prime contractor. It is dedicated to rapidly translating basic research into new technologies for diagnosing, treating, and preventing cancer and AIDS. It will maintain a full suite of advanced technologies in areas such as nanotechnology, genomics and imaging; the federal government’s only drug and vaccine manufacturing facilities; and high-performance Advanced Biomedical Computing Center.  “The NCI has identified an urgent need to convert basic research findings into effective cancer treatments that can be delivered to patients right away,” said Larry O. Arthur, Ph.D., president of SAIC-Frederick. “The consolidation of our operations into modern facilities will enable us to do just that, with the specific goal of shortening timelines, reducing costs, and increasing productivity—all of which will benefit cancer patients and people at risk for cancer.”

Photo Credit: Courtesy of SAIC-Frederick